"Breakthrough: Australia pioneers MDMA therapy for PTSD treatment"

Australia has become the first country to allow psychiatrists to widely prescribe MDMA for the treatment of post-traumatic stress disorder (PTSD). The Therapeutic Goods Administration has rescheduled MDMA from a prohibited to a controlled substance, making Australia a countrywide experiment for other jurisdictions to observe. MDMA floods the brain with feel-good chemicals and curtails fear, allowing patients to examine past traumatic experiences while avoiding typical responses like avoidance and defensiveness. Clinical trials have shown significant improvement in PTSD patients after MDMA-assisted therapy. However, some experts express concerns about the lack of regulatory framework and potential for boundary crossing in the therapy.